July 20, 2022
PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional)
National Center for Advancing Translational Sciences (NCATS)
The purpose of this Notice is to inform potential applicants of the changes in the Award Information for PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional) for receipt dates of January 13, 2023, May 12, 2023 and September 15, 2023. The Award Budget information is NOT changed for the September 16, 2022 receipt date. Budget limits for future receipt dates will be determined at a later date.
Section II. Award Information
Award Budget
Currently Reads:
Award Budget
The amount of funding that applicants can request depends on the amount of NIH funding they receive. After calculating the total amount of NIH funding received as described in Section IV. Application and Submission Information, 2. Content and Form of Application Submission, R&R Budget, applicants may request the following amounts:
Size Eligibility Budget Tiers for FOA Applicants |
Maximum Direct Cost Budget Requests for UM1 |
|
Hub Tier |
5-year average of the most current NIH Direct Cost (DC) Funding of the applicant institution, PLUS 5-year average of the most current Total Cost (TC) NIH funding in Clinical Research category of any partner(s)* (based on FY2016-FY2020 NIH Funding data) |
UM1 |
A |
>$300,000,000 |
$6,500,000 |
C |
$220,000,000 - $300,000,000 |
$5,000,000 |
T |
$135,000,000 - $219,999,999 |
$3,600,000 |
G |
<$135,000,000 |
$2,600,000 |
Revised to Read:
Award Budget
The amount of funding that applicants can request depends on the amount of NIH funding they receive. After calculating the total amount of NIH funding received as described in Section IV. Application and Submission Information, 2. Content and Form of Application Submission, R&R Budget, applicants may request the following amounts:
Size Eligibility Budget Tiers for FOA Applicants |
Maximum Direct Cost Budget Requests for UM1 |
|
Hub Tier |
5-year average of the most current NIH Direct Cost (DC) Funding of the applicant institution, PLUS 5-year average of the most current NIH Direct Cost (DC) funding of any partner(s)* (based on FY2017-FY2021 NIH Funding data) |
UM1 |
A |
>$320,000,000 |
$6,500,000 |
C |
$235,000,000 - $320,000,000 |
$5,000,000 |
T |
$145,000,000 - $234,999,999 |
$3,600,000 |
G |
<$145,000,000 |
$2,600,000 |
All other aspects of the Funding Opportunity Announcement remain unchanged.
Erica Rosemond, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-594-8927
Email: [email protected]